MedTrace Pharma A/S — Credit Rating and Financial Key Figures

MedTrace Pharma A/S (CVR number: 36497661) is a company from RUDERSDAL. The company recorded a gross profit of 1060.5 kDKK in 2019. The operating profit was 210.6 kDKK, while net earnings were -1001.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 0.7 %, which can be considered weak but Return on Equity (ROE) was -16.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 15.5 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. MedTrace Pharma A/S's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.